Clinical Trial Update: Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing safety and efficacy of Afalaza for symptoms and progression risk in benign prostatic hyperplasia; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Afalaza

Snippet

Sponsor: Materia Medica Holding | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2018-10-09